Breast and Ovarian Cancer
Rs.29,995.00 Rs.60,000.00
Breast and Ovarian Cancer
Breast cancer is one of the most common cancers in the world affecting ~12.5% of women during their lifetime. 5–10% of these patients have a hereditary form.
Mutations in the BRCA1 and BRCA2 genes are the most common hereditary cause. However, other genes such as ATM, BRIP1, CHEK2, PALB2, RAD51, etc. have also been associated with increased risk.
Choose Quantity
Product Details
| Gene test | BRCA1/BRCA2 | Breast and Ovarian Cancer |
| Gene name | BRCA1, BRCA2 | ABRAXAS1, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, DICER1, EPCAM, FANCC, MEN1, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS1, PMS2, PTEN, RAD50, RAD51C, RAD51D, RECQL, SMARCA4, STK11, TP53, XRCC2 |
| Diseases covered | Breast cancer | Breast cancer, ovarian cancer |
| Turnaround time | 15 business days | 15 business days |
| How to order | Order a test | Order a test |
Early detection of breast cancer significantly prolongs survival prospects and offers many opportunities for early treatment or management. Apart from generally recommended breast cancer prevention actions, people with an increased risk due to inherited mutations in breast cancer genes should be offered additional programs, according to the guidelines and to the estimated risk for breast and other associated tumors.
